Month: March 2024

2071 posts
Milliken & Company Recognized Among the 2024 World's Most Ethical Companies®

Milliken & Company Recognized Among the 2024 World's Most Ethical Companies®

SPARTANBURG, S.C., March 4, 2024 /PRNewswire/ — Diversified global manufacturer Milliken &…
SKF Annual Report 2023 published online; on track to deliver on 2030 sustainability target

SKF Annual Report 2023 published online; on track to deliver on 2030 sustainability target

GOTHENBURG, Sweden, March 4, 2024 /PRNewswire/ — AB SKF’s Annual Report 2023…
SunCar Technology Group Inc. to Present at the Citizens JMP Technology Conference

SunCar Technology Group Inc. to Present at the Citizens JMP Technology Conference

NEW YORK, March 4, 2024 /PRNewswire/ — SunCar Technology Group Inc. (the "Company"…
Ethisphere recognizes Infosys among 2024 World's Most Ethical Companies® for the Fourth Consecutive Year

Ethisphere recognizes Infosys among 2024 World's Most Ethical Companies® for the Fourth Consecutive Year

Highlights Infosys’ commitment to business integrity through robust ethics, compliance, and governance…
Iridium to Expand its Reach as a Global Alternative PNT Service with Acquisition of Market Leader Satelles

Iridium to Expand its Reach as a Global Alternative PNT Service with Acquisition of Market Leader Satelles

Iridium’s advanced portfolio of easily integrated assured PNT solutions will protect global…
Canadian Solar Partners with Sol Systems to Ramp Up U.S. Module Manufacturing

Canadian Solar Partners with Sol Systems to Ramp Up U.S. Module Manufacturing

GUELPH, ON, March 4, 2024 /PRNewswire/ — Canadian Solar Inc. (the "Company" or "Canadian…
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

MANCHESTER, England, March 4, 2024 /PRNewswire/ — Phagenesis, a pioneering UK company…
Landmark Clinical Approval for YOLT-201 Obtained by the NMPA

Landmark Clinical Approval for YOLT-201 Obtained by the NMPA

SHANGHAI, March 4, 2024 /PRNewswire/ — YolTech Therapeutics, a biotech company developing…